Bacteria platform to deliver RNA and protein
We have a strong preclinical pipeline fully owned and IP-protected. Our engineered bacteria deliver diverse cargos larger than other vehicles can handle, and are equipped with safety switches and other smart controls.
- Lead asset RONC1 against pancreatic cancer
- Collaboration with large-cap pharma in progress
Target the right cells in the right tissues
Enhance efficacy where needed